.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Fuji
Express Scripts
Colorcon
Johnson and Johnson
Moodys
Federal Trade Commission
McKinsey
Mallinckrodt

Generated: July 25, 2017

DrugPatentWatch Database Preview

IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Ionosol Mb And Dextrose 5% In Plastic Container, and what generic Ionosol Mb And Dextrose 5% In Plastic Container alternatives are available?

Ionosol Mb And Dextrose 5% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium lactate; sodium phosphate, monobasic anhydrous. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium lactate; sodium phosphate, monobasic anhydrous profile page.

Summary for Tradename: IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list105,072
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER
dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium lactate; sodium phosphate, monobasic anhydrous
INJECTABLE;INJECTION019513-001May 8, 1986RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Chubb
Citi
Argus Health
Merck
Harvard Business School
QuintilesIMS
Fuji
Cerilliant
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot